Pulmatrix, Inc. (PULM): Insider Trading, Congress Trades & Research | Tormere

PULM

$1.52+14.29%visit website

Pulmatrix, Inc.

Market Cap

$6M

Live price × SEC shares (Aug 13, 2026)

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

1.98

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

2.2

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Research & development	8.0	(3.0)	3.0	2.0	10.0
Total operating expenses	866	908	1,292	1,046	4,112
Operating income	(866)	(908)	(1,292)	(1,046)	(4,112)
Income tax	0.00	0.00
Net income	(877)	(928)	(1,172)	(1,036)	(4,013)
EPS (basic) ($)	(0.24)		(0.32)	(0.29)	(1.10)
EPS (diluted) ($)	(0.24)		(0.32)	(0.29)	(1.10)
Weighted avg. shares (basic)	3,652		3,652	3,652
Weighted avg. shares (diluted)	3,652		3,652	3,652

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 13, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 49 more quarters, back to Jun 2013, with Tormere Pro.

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

No Form 4 transactions on record.

Recent News

Eos SENOLYTIX Reports Interim Data Showing Preserved Physical Function with MitoXcel Geropeptide PTC-2105 in a Second Species, Aged-Rat Study

Yahoo · 2026-10-30

Up to 491,607 Pulmatrix (PULM) shares are registered for resale; the company gets no proceeds.

Stock Titan · 2026-10-26

Pulmatrix, Inc. SEC Filing (Oct 23, 2026)

Stock Titan · 2026-10-23

Eos SENOLYTIX Presents Late-Life Survival and Healthspan Data for Mitochondria-Targeted Geropeptide PTC-2105 at the 17th World Congress on Targeting Mitochondria, and Launches “Team Speedy” to Let the Public Follow Its Longest-Lived Mouse

Yahoo · 2026-10-22

Eos SENOLYTIX Presents New Preclinical Survival, Healthspan, Mechanism-Of-Action Data For Its PTC-2105 Candidate At 17th World Congress On Targeting Mitochondria 2026

Benzinga · 2026-10-22

Pulmatrix Receives Notice Of Allowance For U.S. Patent Covering Dry Powder Dihydroergotamine Formulations For Migraine

Benzinga · 2026-10-21

Pulmatrix (PULM) Slips 4.39% to $1.46, Drifting Toward Lower Support - Symmetrical Triangle

https://www.siam.in/ · 2026-10-11

Eos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting Mitochondria

Yahoo Finance · 2026-09-22

Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger

Yahoo Finance · 2026-08-13

Pulmatrix Announces First Quarter 2026 Financial Results

Yahoo Finance · 2026-05-15

Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger

PR Newswire · 2026-04-21

PULM Stock Alert: Halper Sadeh LLC is Investigating Whether Pulmatrix, Inc. is Obtaining a Fair Price for its Shareholders

Business Wire · 2026-04-13

Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan

Yahoo Finance · 2026-03-26

Wave crashes on obesity drug update; Kodiak’s reboot pays dividends

Yahoo Finance · 2026-03-26

symbol__ Stock Quote Price and Forecast

CNN · 2024-04-08

Informational purposes only, not investment advice.